TD Cowen analyst Dan Brennan reiterated a Buy rating on Singular Genomics (NASDAQ: OMIC).The analyst commented, "In a quiet print ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE